DataMeds AI, Inc. (MEDS)
1.16
-0.06
(-4.92%)
USD |
NASDAQ |
Nov 06, 10:24
DataMeds AI Enterprise Value : 33.79M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 33.79M |
| November 04, 2026 | 34.56M |
| November 03, 2026 | 35.44M |
| November 02, 2026 | 35.52M |
| October 30, 2026 | 35.78M |
| October 29, 2026 | 36.09M |
| October 28, 2026 | 36.57M |
| October 27, 2026 | 36.18M |
| October 26, 2026 | 36.54M |
| October 23, 2026 | 36.66M |
| October 22, 2026 | 36.86M |
| October 21, 2026 | 38.05M |
| October 20, 2026 | 38.13M |
| October 19, 2026 | 37.91M |
| October 16, 2026 | 37.79M |
| October 15, 2026 | 38.42M |
| October 14, 2026 | 38.42M |
| October 13, 2026 | 38.93M |
| October 12, 2026 | 39.04M |
| October 09, 2026 | 38.73M |
| October 08, 2026 | 39.98M |
| October 07, 2026 | 38.50M |
| October 06, 2026 | 39.04M |
| October 05, 2026 | 39.83M |
| October 02, 2026 | 40.77M |
| Date | Value |
|---|---|
| October 01, 2026 | 41.85M |
| September 30, 2026 | 39.32M |
| September 29, 2026 | 40.74M |
| September 28, 2026 | 41.14M |
| September 25, 2026 | 39.15M |
| September 24, 2026 | 40.26M |
| September 23, 2026 | 41.20M |
| September 22, 2026 | 42.46M |
| September 21, 2026 | 42.19M |
| September 18, 2026 | 41.00M |
| September 17, 2026 | 43.49M |
| September 16, 2026 | 47.55M |
| September 15, 2026 | 34.93M |
| September 14, 2026 | 32.79M |
| September 11, 2026 | 32.89M |
| September 10, 2026 | 32.86M |
| September 09, 2026 | 32.75M |
| September 08, 2026 | 32.80M |
| September 04, 2026 | 32.93M |
| September 03, 2026 | 33.06M |
| September 02, 2026 | 33.25M |
| September 01, 2026 | 33.14M |
| August 31, 2026 | 33.06M |
| August 28, 2026 | 33.06M |
| August 27, 2026 | 33.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 11.35M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | 1.943M |
| Vivos Therapeutics, Inc. | 13.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.36M |
| Revenue (Quarterly) | 1.780M |
| Total Expenses (Quarterly) | 20.14M |
| EPS Diluted (Quarterly) | -7.132 |
| Gross Profit Margin (Quarterly) | -9.80% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -3.73K% |
| Normalized Earnings Yield | -3037.44 |